The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom
Linlin Yang,1,2 Xin Chen,3 Zhiqi Liu,3 Wei Sun,3 Dexin Yu,3 Haiqin Tang,1,2,* Zhiqiang Zhang3,* 1Department of Geriatrics Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China; 2Department of General Medicine, The First Affiliated Ho...
Guardado en:
Autores principales: | Yang L, Chen X, Liu Z, Sun W, Yu D, Tang H, Zhang Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/33b88e3ce9d34b529c4f2d822153b061 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis
por: Wang XY, et al.
Publicado: (2016) -
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
por: Amr Fawzi, et al.
Publicado: (2017) -
Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
por: D Gnyawali, et al.
Publicado: (2016) -
Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
por: Zhang LT, et al.
Publicado: (2015) -
Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Claus G Roehrborn, et al.
Publicado: (2008)